You are here

  • Home
  • Archive
  • Volume 28, Issue 4
  • A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes–Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer

Article metrics

Article menu
Download PDFPDF
Cervical Cancer
A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes–Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer

 

Online download statistics by month:

Online download statistics by month: February 2019 to September 2024

AbstractFullPdf
Feb 2019600
Mar 20193901
Apr 20195801
May 20199101
Jun 20193201
Jul 20197701
Aug 20196901
Sep 20195900
Oct 20194900
Nov 20195801
Dec 20194700
Jan 20207700
Feb 20209801
Mar 20204100
Apr 20204500
May 20205301
Jun 20205000
Jul 20206000
Aug 20204401
Sep 20205001
Oct 20204104
Nov 20204302
Dec 20202901
Jan 20214402
Feb 20218702
Mar 20219400
Apr 20217401
May 20212300
Jun 2021700
Jul 2021301
Aug 2021201
Sep 2021401
Oct 20217402
Nov 20219401
Dec 20217302
Jan 20226501
Feb 20229202
Mar 202224302
Apr 20228402
May 202213400
Jun 202212400
Jul 20228601
Aug 202216000
Sep 202215102
Oct 202210900
Nov 202211703
Dec 202211800
Jan 202327605
Feb 202317002
Mar 202322103
Apr 202321103
May 20237203
Jun 20237704
Jul 20234202
Aug 20235900
Sep 202314400
Oct 202337100
Nov 202355900
Dec 202322400
Jan 202411200
Feb 202414500
Mar 202414201
Apr 202410501
May 202412300
Jun 202421801
Jul 202412102
Aug 20246201
Sep 202415800
Total6890072